黄酮类化合物防治糖尿病微血管病变的研究进展
郭苏 , 秦小江 , 江雪露 , 方梦薇 , 满志 , 孟欣 , 郑志发 , 赵良渊 , 施熠炜 , 侯晓敏
中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (6) : 752 -763.
黄酮类化合物防治糖尿病微血管病变的研究进展
Research progress on flavonoids in the prevention and treatment of diabetic microvascular complications
糖尿病是一种以慢性高血糖为特征的常见代谢性疾病。长期高血糖可损伤全身微血管,包括视网膜、肾小球、神经营养血管及心肌微小冠状动脉等,临床表现为糖尿病视网膜病变(diabetic retinopathy,DR)、糖尿病肾病(diabetic kidney disease,DKD)、糖尿病神经病变(diabetic neuropathy,DN)和糖尿病心肌病变(diabetic cardiomyopathy,DCM)。这些并发症严重影响患者生活质量,甚至危及生命。糖尿病微血管病变的发病机制与高血糖诱导的代谢途径异常激活、氧化应激及炎症反应等密切相关,最终导致微血管内皮功能损伤、基底膜增厚和微循环障碍。黄酮类化合物作为一类广泛存在于植物中的天然产物,具有抗炎、抗氧化和保护血管内皮等多种生物活性,在防治糖尿病微血管病变方面展现出巨大潜力。本文综述了近年来黄酮类化合物在该领域的研究进展,并探讨了其在临床应用中的挑战和未来发展方向,以期为后续开发和应用提供参考。
Diabetes mellitus is a common metabolic disease characterized by chronic hyperglycemia. Prolonged elevated blood glucose levels damage microvasculature throughout the body (including those in the retina, renal glomeruli, vasa nervorum, and intramyocardial small coronary arteries). This leads to clinical manifestations such as diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, and diabetic cardiomyopathy, all of which significantly impair the patient's quality of life and can even pose fatal risks. The pathogenesis of diabetic microvascular complications is closely associated with pathological changes induced by hyperglycemia, including the abnormal activation of multiple metabolic pathways, oxidative stress, and inflammatory responses, among other factors. These processes ultimately lead to pathological alterations, including microvascular endothelial dysfunction, basement membrane thickening, and microcirculatory disturbances. Flavonoids, a broad class of naturally occurring compounds ubiquitous in plants, possess a wide range of biological activities, such as anti-inflammatory, antioxidant, and endothelium-protective effects, which render them highly promising for preventing and treating diabetic microvascular complications. This review summarizes recent advances in the study of flavonoids for preventing and treating diabetic microvascular complications. Furthermore, it discusses the current challenges and future directions for the clinical use of flavonoids, aiming to provide a comprehensive reference for their continued development and applications.
| [1] |
Roy B. Pathophysiological mechanisms of diabetes-induced macrovascular and microvascular complications: the role of oxidative stress[J].Med Sci, 2025, 13(3): 87. |
| [2] |
|
| [3] |
丁浚峰, 涂珺. 中药治疗糖尿病微血管病变的研究进展[J].中国实验方剂学杂志, 2023, 29(6): 260-267. |
| [4] |
|
| [5] |
何婉如, 张晓熙, 徐长玉, |
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
Rojas A, Lindner C, Schneider I, |
| [17] |
Yamaguchi H, |
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
Seo H, |
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
Lerner G. Investigation of diabetic kidney disease in the network for pancreatic organ donors with diabetes-kidney cohort[J].Kidney360, 2025, 6(1): 1-3. |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
刘世林, 李安冬, 南征, |
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
Oh YS. Bioactive compounds and their neuroprotective effects in diabetic complications[J].Nutrients, 2016, 8(8): 472. |
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
刘丹, 苗加伟, 谭子豪, |
| [52] |
|
| [53] |
|
| [54] |
Reis A, Rocha S, |
| [55] |
Hakami T, Mahmoud MI, de Juan E, |
| [56] |
|
| [57] |
Liu L, Barber E, |
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
Mao Y, Luo J, |
| [67] |
|
国家自然科学基金青年基金项目(82204042)
国家自然科学基金面上项目(82373622)
山西省科技创新人才团队(青年)项目(202304051001038)
山西省科技合作交流专项项目(区域合作项目)(2022040411022)
国家卫生健康委员会尘肺病重点实验室开放课题(NHC202307)
山西省高等教育“百亿工程”科技引导专项(BYJL067)
/
| 〈 |
|
〉 |